"[The CDC] examined 43 cities and found that so-called nonpharmaceutical interventions -- steps such as isolating patients and school closings -- were remarkably successful in tamping down the outbreak." ❋ Unknown (2009)
The strategy has run counter to those pursued by rivals, including Pfizer, which have gotten bigger and diversified into nonpharmaceutical areas. ❋ Peter Loftus (2011)
CEO Mr. Frazier hinted Friday that Merck wasn't likely to divest itself of some of the nonpharmaceutical businesses Merck acquired in the Schering deal. ❋ Peter Loftus (2011)
Bristol in recent years has shed nonpharmaceutical assets, such as baby formula Enfamil, and made acquisitions to bolster its drug pipeline, including the $2.3 billion acquisition in 2009 of Medarex Inc., which developed Yervoy. ❋ Thomas Gryta (2011)
In recent years, Bristol has pursued a strategy of shedding its nonpharmaceutical assets, such as baby formula Enfamil, and using proceeds to make modest-sized acquisitions to bolster its drug portfolio. ❋ Peter Loftus (2011)
When she and I discussed my research on the uses of nonpharmaceutical interventions (NPIs) for pandemic mitigation, I clearly stated that hand-washing and social distancing alone would not protect the majority of Americans from a severe influenza pandemic. ❋ Unknown (2009)
Do we understand the longterm effectiveness of these medications compared to meaningful nonpharmaceutical intervention? ❋ M.D. Maggie Kozel (2011)
Pfizer accelerated its "shareholder-friendly" measures earlier this year by expanding a share repurchase program and setting a course to divest itself of certain nonpharmaceutical businesses. ❋ Peter Loftus (2011)
He was known during a nearly four-year tenure as chief executive of Bristol-Myers for shedding the company's nonpharmaceutical assets while many competitors diversified and got bigger. ❋ Kathy Shwiff (2011)
Pfizer is in the midst of exploring the potential divestiture of nonpharmaceutical assets, including its animal-health and nutrition units. ❋ Peter Loftus (2011)
Bristol's research-and-development victories followed a shift in strategy several years ago, when the company began shedding nonpharmaceutical assets and cutting costs. ❋ Peter Loftus (2012)
Speculation has mounted recently that Pfizer may sell or spin off most of its nonpharmaceutical businesses, which include nutrition, consumer-health and animal-health units. ❋ Peter Loftus (2011)
It's the first such meeting since late 2007, when Bristol announced a shift in strategy — it would divest itself of nonpharmaceutical assets including a baby-formula business, and use the proceeds to beef up its drug portfolio. ❋ Peter Loftus (2010)
We believe you should try nonpharmaceutical options first. ❋ William Kent Krueger (2010)
